N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists

Details N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists

2006-05-30

2006-05-30

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S255050, C514S256000, C514S263220, C514S275000, C514S318000, C514S322000, C514S326000, C544S238000, C544S264000, C544S328000, C544S329000, C544S330000, C544S331000, C544S332000, C544S336000, C544S409000, C546S194000, C546S208000, C546S209000

Reexamination Certificate

active

07053089

ABSTRACT:
Compounds represented by Formula (I):or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for relieving pain.

REFERENCES:
patent: 3184462 (1965-05-01), Scarborough et al.
patent: 4197304 (1980-04-01), Sanczuk et al.
patent: 5306723 (1994-04-01), Chenard
patent: 5436255 (1995-07-01), Butler
patent: 5861396 (1999-01-01), Niewohner et al.
patent: 6020347 (2000-02-01), DeLazlo et al.
patent: 6124323 (2000-09-01), Bigge et al.
patent: 6300333 (2001-10-01), Schaper et al.
patent: 23 41 965 (1975-03-01), None
patent: 4241632 (1994-06-01), None
patent: 441506 (1991-08-01), None
patent: 532456 (1993-03-01), None
patent: 604800 (1994-07-01), None
patent: 611660 (1994-08-01), None
patent: 771779 (1997-05-01), None
patent: 787493 (1997-08-01), None
patent: 846683 (1998-06-01), None
patent: 2758328 (1998-07-01), None
patent: WO 91/17156 (1991-11-01), None
patent: WO 91/19709 (1991-12-01), None
patent: WO 92/18502 (1992-10-01), None
patent: WO 93/02052 (1993-02-01), None
patent: WO 93/17017 (1993-09-01), None
patent: WO 94/20062 (1994-02-01), None
patent: WO 94/14776 (1994-07-01), None
patent: WO 94/21615 (1994-09-01), None
patent: WO 96/02250 (1996-02-01), None
patent: WO 96/10035 (1996-04-01), None
patent: WO 96/34856 (1996-11-01), None
patent: WO 96/37226 (1996-11-01), None
patent: WO 97/19065 (1997-05-01), None
patent: WO 97/28141 (1997-08-01), None
patent: WO 97/43279 (1997-11-01), None
patent: WO 97/45119 (1997-12-01), None
patent: WO 98/04913 (1998-02-01), None
patent: WO 98/05336 (1998-02-01), None
patent: WO 98/31669 (1998-07-01), None
patent: WO 98/31677 (1998-07-01), None
patent: WO 98/46589 (1998-10-01), None
patent: WO 99/25685 (1999-05-01), None
patent: WO 99/51589 (1999-10-01), None
patent: WO 00/00197 (2000-01-01), None
patent: WO 00/08015 (2000-02-01), None
patent: WO 00/11002 (2000-03-01), None
patent: WO 00/25786 (2000-05-01), None
patent: WO 00/61551 (2000-10-01), None
patent: WO 01/00207 (2001-01-01), None
Zhu et al., Chem. Abstract 95:150311, 1981.
Moragues et al., Chem. Abstract 94:24760, 1981.
Electronic Database Printout, Derwent 93-087414/11, CIBA Geigy AG, EP 532456-A1, 1993.
Electronic Database Printout, Derwent 2000-225262/20, Bayer AG, DE 19835300-A1, 2000.
Electronic Database Printout, Derwent 98-390317/34, Fabre Medicament SA Pierre, FR 2758327-A1, 1998.
Electronic Database Printout, Derwent 98-390318/34, Fabre Medicament SA Pierre, FR 2758328-A1, 1998.
Electronic Database Printout, Derwent 97-414968/38, Fabre Medicament SA Pierre, WO 9728141-A1, 1997.
R. Jain, et al., Tetrahedron, 54:3235-3242(1998).
W. Daysz, et al., Pharmacological Rev., 50:597-664(1998).
R.D. Clark, et al., J. Med. Chem., 26:855-861(1983).
A. Dickenson, TIPS,11:307-309(1990).
A. Wenzel, et al., Neurochemistry, 7:45-48(1995).
J.N.C. Kew, et al., Brit. J. Pharmacology, 123:463-472(1998).
Electronic Database Printout, CAPLUS 1999:617466,218th ACS Nat. Mtg., N. Orleans, Aug. 22-26, 1999.
Z.-L. Zhou, et al., J. Med. Chem., 42:2993-3000(1999).
S. Boyce, et al., Neuropharmacology, 38:611-623(1999).
D.J. Laurie, et al., Mol. Brain Res., 51:23-32(1997).
T. Ishii, et al., J. Biol. Chem., 268:2836-2843(1993).
M.B. Max, et al., Clin. Neuropharmacology, 18:360-368(1995).
D.J. Knox, et al., Anaesth. Intens. Care, 23:620-622(1995).
P.K. Eide, et al., Pain, 61:221-228(1995).
J.D. Kristensen, et al., Pain,51:249-253(1992).
K. Taniguchi, et al., Brit. J. Pharmacology, 122:809-812(1997).
U. Lupke, et al., Chem. Ber., 112:3832-3839(1979).
L. Bernadi, et al., Gazz. Chim. Ital., 91:1431-1437(1961).
M.J. Kornet, et al., J. Organic Chemistry, 33:3637-3639(1968).
A. Albert, et al., J. Chem. Soc., 3832-3839(1954).
T. Riley, et al., J. Med. Chem., 15:1187-1188(1972).
G.C. Finger, et al., J. Organic Chem., 27: 3965-3968(1962).
M. Malinowski, et al., KJ. Prakt. Chem., 330:154-158(1988).
G. B. Eilon, J. Org. Chem., 27:2478-2491(1962).
T. Sawayama, et al., Chem. Pharm, Bull., 38(1):110-115(1990).
Silverstein, Chem. Abstracts, 28:5627, 1963.
S. Nahm, et al., Tetrahedron Letters, 22:3815-3818(1981).
P.E. Maligres et al., Tetrahedron, 53:10983(1997).
P. Rocca, et al., Tetrahedron, 49:49-64(1993).
N. B. Chapman, et al., J. Chem. Soc., 890-899(1947).
S.R. Brashears, et al., J. Am. Chem. Soc., 81:3789-3792(1959).
G. D. Davies, et al., J. Heterocyclic Chem., 1:130-131(1964).
W. J. Link, et al., Heterocyclic Chem., 4:641-643(1967).
Y. Mizuno, et al., Chem. Pharm. Bull., 12:866-872(1964).
Electronic Database Printout, Derwent 94-201126/25, DE 4241632-A1,1994.
Electronic Database Printout, Marpat 121:133976, DE 4241632, 1994.
Electronic Database Printout, Marpat 127:220673, WO 9728141, 1997.
Electronic Printout Marpat, 129:175651, FR 2758328, 1998.
Isabelle Parrot, et al.,Synthesis of Substituted 3-Amino-6-arylpyridazines via Susuki Reaction, vol. No. 7, pp. 1163-1168, (1999).
J. Moragues, et al.,Dopaminergic Activity in a Series of N-Substituted 2-Aminopyrimidines, vol. No. 35, pp. 951-964, (1980).

Affiliated with

Also associated with

Rating

N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3612650